Free Trial

Microvast (NASDAQ:MVST) Hits New 12-Month High - Here's Why

Microvast logo with Business Services background

Microvast Holdings, Inc. (NASDAQ:MVST - Get Free Report)'s stock price reached a new 52-week high on Tuesday . The company traded as high as $3.60 and last traded at $3.59, with a volume of 15621255 shares traded. The stock had previously closed at $3.38.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a "buy" rating and issued a $3.00 target price on shares of Microvast in a research report on Tuesday, April 8th.

Read Our Latest Stock Analysis on Microvast

Microvast Stock Up 6.2%

The stock has a 50-day moving average of $1.89 and a two-hundred day moving average of $1.64. The company has a market cap of $1.17 billion, a P/E ratio of -9.45 and a beta of 2.72. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.83 and a current ratio of 1.30.

Microvast (NASDAQ:MVST - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.10. The business had revenue of $116.49 million for the quarter, compared to analysts' expectations of $104.00 million. Microvast had a negative return on equity of 22.10% and a negative net margin of 30.88%. On average, research analysts anticipate that Microvast Holdings, Inc. will post -0.3 EPS for the current fiscal year.

Hedge Funds Weigh In On Microvast

Large investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets purchased a new position in Microvast in the 4th quarter worth approximately $25,000. SBI Securities Co. Ltd. purchased a new position in Microvast in the 4th quarter worth approximately $32,000. IMG Wealth Management Inc. purchased a new position in Microvast in the 4th quarter worth approximately $38,000. Prudential Financial Inc. purchased a new position in shares of Microvast during the fourth quarter valued at approximately $55,000. Finally, Schonfeld Strategic Advisors LLC purchased a new position in shares of Microvast during the fourth quarter valued at approximately $73,000. 20.72% of the stock is owned by hedge funds and other institutional investors.

Microvast Company Profile

(Get Free Report)

Microvast Holdings, Inc provides battery technologies for electric vehicles and energy storage solutions. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, and nickel manganese cobalt version 1 and 2. It also designs, develops, and manufactures battery components, such as cathode, anode, electrolyte, and separator.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Microvast Right Now?

Before you consider Microvast, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microvast wasn't on the list.

While Microvast currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines